rs201975029
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM2PM5BP4_Strong
The NM_019109.5(ALG1):c.827G>A(p.Arg276Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000772 in 1,611,896 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R276W) has been classified as Pathogenic.
Frequency
Consequence
NM_019109.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALG1 | NM_019109.5 | c.827G>A | p.Arg276Gln | missense_variant | 7/13 | ENST00000262374.10 | NP_061982.3 | |
ALG1 | NM_001330504.2 | c.494G>A | p.Arg165Gln | missense_variant | 7/13 | NP_001317433.1 | ||
ALG1 | XM_017023457.3 | c.827G>A | p.Arg276Gln | missense_variant | 7/12 | XP_016878946.1 | ||
ALG1 | XR_007064892.1 | n.834G>A | non_coding_transcript_exon_variant | 7/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALG1 | ENST00000262374.10 | c.827G>A | p.Arg276Gln | missense_variant | 7/13 | 1 | NM_019109.5 | ENSP00000262374 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000651 AC: 162AN: 248660Hom.: 0 AF XY: 0.000659 AC XY: 89AN XY: 135010
GnomAD4 exome AF: 0.000805 AC: 1175AN: 1459596Hom.: 0 Cov.: 41 AF XY: 0.000821 AC XY: 596AN XY: 726148
GnomAD4 genome AF: 0.000453 AC: 69AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.000456 AC XY: 34AN XY: 74480
ClinVar
Submissions by phenotype
ALG1-congenital disorder of glycosylation Pathogenic:2Uncertain:1Benign:1
Likely pathogenic, no assertion criteria provided | clinical testing | Genomics England Pilot Project, Genomics England | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jul 29, 2019 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 30, 2020 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26931382, 20679665) - |
ALG1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 16, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at